Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Circulation. Cardiovascular Interventions
|
January 21, 2026
Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed Studies
Mark J Ricciardi, Gagan Singh, Jason H Rogers, et al.
Circulation. Cardiovascular Interventions
|
December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents
Akiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
JACC. Cardiovascular Interventions
|
January 8, 2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)
Ajay J Kirtane, Puja B Parikh, Thomas D Stuckey, et al.
Journal of the American College of Cardiology
|
February 26, 2021
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure
Michael J Mack, JoAnn Lindenfeld, William T Abraham, et al.
The American Journal of Cardiology
|
September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)
Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.
Circulation. Cardiovascular Interventions
|
February 15, 2017
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents)
Jennifer Yu, Roxana Mehran, Usman Baber, et al.
JACC. Cardiovascular Interventions
|
August 7, 2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study
Thomas D Stuckey, Ajay J Kirtane, Bruce R Brodie, et al.
The American Journal of Cardiology
|
December 8, 2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)
Mikkel M Schoos, George D Dangas, Roxana Mehran, et al.
International Journal of Cardiology
|
January 2, 2017
Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents
Philippe Généreux, Björn Redfors, Bernhard Witzenbichler, et al.
Journal of the American Heart Association
|
December 24, 2022
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES
Bahira Shahim, Björn Redfors, Thomas D Stuckey, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Circulation. Cardiovascular Interventions
|
January 21, 2026
Atrial Secondary Mitral Regurgitation Outcomes Following Mitral Transcatheter Edge-to-Edge Repair: Results From the EXPANDed Studies
Mark J Ricciardi, Gagan Singh, Jason H Rogers, et al.
Circulation. Cardiovascular Interventions
|
December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents
Akiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
JACC. Cardiovascular Interventions
|
January 8, 2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)
Ajay J Kirtane, Puja B Parikh, Thomas D Stuckey, et al.
Journal of the American College of Cardiology
|
February 26, 2021
3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure
Michael J Mack, JoAnn Lindenfeld, William T Abraham, et al.
The American Journal of Cardiology
|
September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)
Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.
Circulation. Cardiovascular Interventions
|
February 15, 2017
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents)
Jennifer Yu, Roxana Mehran, Usman Baber, et al.
JACC. Cardiovascular Interventions
|
August 7, 2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study
Thomas D Stuckey, Ajay J Kirtane, Bruce R Brodie, et al.
The American Journal of Cardiology
|
December 8, 2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)
Mikkel M Schoos, George D Dangas, Roxana Mehran, et al.
International Journal of Cardiology
|
January 2, 2017
Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents
Philippe Généreux, Björn Redfors, Bernhard Witzenbichler, et al.
Journal of the American Heart Association
|
December 24, 2022
On-Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two-Year Results From ADAPT-DES
Bahira Shahim, Björn Redfors, Thomas D Stuckey, et al.
Page
of 8